Clinical trial
RHIV A Pilot Study Refractory or Intolerant to Highly Active Antiretroviral…
NCT00157027 · Atlantic Health System, Other · Withdrawn
Key facts
| NCT number | NCT00157027 |
|---|---|
| Title | RHIV A Pilot Study Refractory or Intolerant to Highly Active Antiretroviral Therapy (HAART) |
| Official title | The Use of Extracorporeal Photochemotherapy With UVADEX in Patients With HIV Who Are Refractory or Intolerant to HAART |
| Acronym | HIV-HAART |
| Lead sponsor | Atlantic Health System, Other |
| Collaborators | Therakos Industry |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Procedure |
| Interventions | Extracorporeal photochemotherapy with UVADEX |
| Enrollment | 0 |
| Start date | Dec 1, 2003 |
| Completion | Apr 1, 2010 |
| First posted | Sep 12, 2005 |
| Last update posted | Jan 16, 2014 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: